TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the ...

Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...

The serine/threonine protein phosphatase 5 (PP5) regulates hormone and stress-induced signaling networks. Unlike other phosphoprotein phosphatases, PP5 contains both regulatory and catalytic domains ...

A study led by the Department of Energy's Oak Ridge National Laboratory details how artificial intelligence researchers have ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...

After opening two area restaurants in two years, two Jacksonville brothers have opened a third location of their ...

IBI363 has earned fast track designation from the FDA for the treatment of previously treated unresectable advanced melanoma.

Thankfully, healthy snacking is possible. For example, choosing a high-protein snack between breakfast and lunch or before dinner can help keep you full and satisfied. Although everyone's daily ...

As a First in-class PD-1/IL-2α-bias bispecific antibody fusion protein, IBI363 monotherapy has shown encouraging efficacy and a favorable safety profile in melanoma subjects who have previously ...